- Home
- ELTK vs JSPR Comparison
ELTK vs JSPR Comparison
Compare ELTK & JSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELTK
- JSPR
- Stock Information
- Founded
- ELTK 1970
- JSPR 2018
- Country
- ELTK Israel
- JSPR United States
- Employees
- ELTK N/A
- JSPR N/A
- Industry
- ELTK Electrical Products
- JSPR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ELTK Technology
- JSPR Health Care
- Exchange
- ELTK Nasdaq
- JSPR Nasdaq
- Market Cap
- ELTK 76.9M
- JSPR 68.4M
- IPO Year
- ELTK 1997
- JSPR N/A
- Fundamental
- Price
- ELTK $8.62
- JSPR $1.70
- Analyst Decision
- ELTK
- JSPR Buy
- Analyst Count
- ELTK 0
- JSPR 12
- Target Price
- ELTK N/A
- JSPR $25.60
- AVG Volume (30 Days)
- ELTK 4.1K
- JSPR 431.6K
- Earning Date
- ELTK 11-18-2025
- JSPR 11-10-2025
- Dividend Yield
- ELTK 2.32%
- JSPR N/A
- EPS Growth
- ELTK N/A
- JSPR N/A
- EPS
- ELTK 0.17
- JSPR N/A
- Revenue
- ELTK $49,310,000.00
- JSPR N/A
- Revenue This Year
- ELTK $18.60
- JSPR N/A
- Revenue Next Year
- ELTK $9.04
- JSPR N/A
- P/E Ratio
- ELTK $49.99
- JSPR N/A
- Revenue Growth
- ELTK 2.54
- JSPR N/A
- 52 Week Low
- ELTK $7.65
- JSPR $1.56
- 52 Week High
- ELTK $12.19
- JSPR $26.05
- Technical
- Relative Strength Index (RSI)
- ELTK 15.43
- JSPR 37.10
- Support Level
- ELTK $8.55
- JSPR $1.56
- Resistance Level
- ELTK $11.59
- JSPR $1.97
- Average True Range (ATR)
- ELTK 0.32
- JSPR 0.18
- MACD
- ELTK -0.41
- JSPR 0.01
- Stochastic Oscillator
- ELTK 0.00
- JSPR 34.28
About ELTK Eltek Ltd.
Eltek Ltd is engaged in the technology business sector that manufactures and supplies technologically new custom-made circuitry solutions. It manufactures, markets, and sells custom-made printed circuit boards (PCBs), including high-density interconnect, flex-rigid and multi-layered boards. The Company markets its products mainly to the medical technology, defense and aerospace, industrial, telecom, and networking equipment industries. Its geographic areas are Israel, North America, the Netherlands, India, and Others. It generates the majority of its revenue from Israel.
About JSPR Jasper Therapeutics Inc.
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.